| Juan Manuel Oliva, MD | |
|
4647 Zion Ave, San Diego, CA 92120-2507 | |
| (619) 528-5000 | |
| Not Available |
| Full Name | Juan Manuel Oliva |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 4647 Zion Ave, San Diego, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023133527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A91940 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Zion | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
As parents send their kids off for the first day of school, it's a good idea to put as much thought into what they're packing in their kids' lunchboxes as they do into their school supplies.
New research investigating serious incidents occurring in the management of patient remains after their death concludes that safe mortuary care may be improved by applying lessons learned from existing patient safety work.
Eisai Co., Ltd. announced today that the Company has in-licensed an anti-hepatitis B agent (generic name: clevudine) from Bukwang Pharm (Headquarters, Seoul, South Korea, President: Sung-Koo Lee).
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
In a publication selected as a "2007 Hot Article" by the journal Biochemistry , University at Buffalo chemists report the discovery of a central mechanism responsible for the action of the powerful biological catalysts known as enzymes.
› Verified 4 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
As parents send their kids off for the first day of school, it's a good idea to put as much thought into what they're packing in their kids' lunchboxes as they do into their school supplies.
New research investigating serious incidents occurring in the management of patient remains after their death concludes that safe mortuary care may be improved by applying lessons learned from existing patient safety work.
Eisai Co., Ltd. announced today that the Company has in-licensed an anti-hepatitis B agent (generic name: clevudine) from Bukwang Pharm (Headquarters, Seoul, South Korea, President: Sung-Koo Lee).
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
In a publication selected as a "2007 Hot Article" by the journal Biochemistry , University at Buffalo chemists report the discovery of a central mechanism responsible for the action of the powerful biological catalysts known as enzymes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Manuel Oliva, MD 4647 Zion Ave, San Diego, CA 92120-2507 Ph: (619) 528-5000 | Juan Manuel Oliva, MD 4647 Zion Ave, San Diego, CA 92120-2507 Ph: (619) 528-5000 |
News Archive
As parents send their kids off for the first day of school, it's a good idea to put as much thought into what they're packing in their kids' lunchboxes as they do into their school supplies.
New research investigating serious incidents occurring in the management of patient remains after their death concludes that safe mortuary care may be improved by applying lessons learned from existing patient safety work.
Eisai Co., Ltd. announced today that the Company has in-licensed an anti-hepatitis B agent (generic name: clevudine) from Bukwang Pharm (Headquarters, Seoul, South Korea, President: Sung-Koo Lee).
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
In a publication selected as a "2007 Hot Article" by the journal Biochemistry , University at Buffalo chemists report the discovery of a central mechanism responsible for the action of the powerful biological catalysts known as enzymes.
› Verified 4 days ago
Dr. Kyle P. Edmonds, M.D., FAAHPM Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr # 8216, San Diego, CA 92103 Phone: 858-534-6091 Fax: 619-543-3947 | |
Jessica C. Cook, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 4291 Robbins St, San Diego, CA 92122 Phone: 858-531-5692 | |
Robina Ahmad, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6973 Linda Vista Rd, San Diego, CA 92111 Phone: 858-279-9676 | |
Dr. Anna M Mercer, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 | |
Bashir A. Rawi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-528-5000 | |
Martin P. Murillo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-528-5000 | |
Erwin Guzman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-528-5000 |